GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) » Definitions » Shiller PE Ratio

Hangzhou Tigermed Consulting Co (HKSE:03347) Shiller PE Ratio : 39.47 (As of Jun. 19, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Hangzhou Tigermed Consulting Co Shiller PE Ratio?

As of today (2024-06-19), Hangzhou Tigermed Consulting Co's current share price is HK$30.00. Hangzhou Tigermed Consulting Co's E10 for the quarter that ended in Mar. 2024 was HK$0.76. Hangzhou Tigermed Consulting Co's Shiller PE Ratio for today is 39.47.

The historical rank and industry rank for Hangzhou Tigermed Consulting Co's Shiller PE Ratio or its related term are showing as below:

HKSE:03347' s Shiller PE Ratio Range Over the Past 10 Years
Min: 28.75   Med: 100.14   Max: 333.96
Current: 37.5

During the past years, Hangzhou Tigermed Consulting Co's highest Shiller PE Ratio was 333.96. The lowest was 28.75. And the median was 100.14.

HKSE:03347's Shiller PE Ratio is ranked worse than
68.75% of 80 companies
in the Medical Diagnostics & Research industry
Industry Median: 27.68 vs HKSE:03347: 37.50

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Hangzhou Tigermed Consulting Co's adjusted earnings per share data for the three months ended in Mar. 2024 was HK$0.293. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is HK$0.76 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Hangzhou Tigermed Consulting Co Shiller PE Ratio Historical Data

The historical data trend for Hangzhou Tigermed Consulting Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Tigermed Consulting Co Shiller PE Ratio Chart

Hangzhou Tigermed Consulting Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 283.12 142.75 92.88 40.98

Hangzhou Tigermed Consulting Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.41 50.62 49.86 40.98 38.84

Competitive Comparison of Hangzhou Tigermed Consulting Co's Shiller PE Ratio

For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou Tigermed Consulting Co's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hangzhou Tigermed Consulting Co's Shiller PE Ratio falls into.



Hangzhou Tigermed Consulting Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Hangzhou Tigermed Consulting Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=30.00/0.76
=39.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou Tigermed Consulting Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Hangzhou Tigermed Consulting Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.293/115.2271*115.2271
=0.293

Current CPI (Mar. 2024) = 115.2271.

Hangzhou Tigermed Consulting Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.051 98.200 0.060
201409 0.060 98.900 0.070
201412 0.076 99.000 0.088
201503 0.075 99.900 0.087
201506 0.075 99.500 0.087
201509 0.065 100.500 0.075
201512 0.083 100.600 0.095
201603 0.072 102.200 0.081
201606 0.060 101.400 0.068
201609 0.035 102.400 0.039
201612 0.066 102.600 0.074
201703 0.068 103.200 0.076
201706 0.114 103.100 0.127
201709 0.128 104.100 0.142
201712 0.167 104.500 0.184
201803 0.159 105.300 0.174
201806 0.199 104.900 0.219
201809 0.227 106.600 0.245
201812 0.234 106.500 0.253
201903 0.227 107.700 0.243
201906 0.313 107.700 0.335
201909 0.260 109.800 0.273
201912 0.464 111.200 0.481
202003 0.376 112.300 0.386
202006 1.083 110.400 1.130
202009 0.440 111.700 0.454
202012 0.581 111.500 0.600
202103 0.620 112.662 0.634
202106 1.111 111.769 1.145
202109 0.723 112.215 0.742
202112 1.543 113.108 1.572
202203 0.740 114.335 0.746
202206 0.914 114.558 0.919
202209 0.537 115.339 0.536
202212 0.514 115.116 0.514
202303 0.752 115.116 0.753
202306 1.039 114.558 1.045
202309 0.601 115.339 0.600
202312 0.186 114.781 0.187
202403 0.293 115.227 0.293

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hangzhou Tigermed Consulting Co  (HKSE:03347) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Hangzhou Tigermed Consulting Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Tigermed Consulting Co (HKSE:03347) Business Description

Traded in Other Exchanges
Address
Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.
Executives
Yi Fang Da Ji Jin Guan Li You Xian Gong Si 2102 Investment manager
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
F-j Sands Family I, Llc 2201 Interest of corporation controlled by you
Sands Frank Melville Jr. 2201 Interest of corporation controlled by you
Sands Family Trust, Llc 2201 Interest of corporation controlled by you
Sands Capital Management, Lp 2201 Interest of corporation controlled by you
Sands Capital Management, Llc 2101 Beneficial owner
2017 Eagle Holdings Llc 2201 Interest of corporation controlled by you
Citigroup Inc. 2201 Interest of corporation controlled by you
Ubs Group Ag 2201 Interest of corporation controlled by you
Blackrock, Inc. 2201 Interest of corporation controlled by you
Brown Brothers Harriman & Co. 2502 Approved lending agent
Ninety One Plc/ Ninety One Ltd 2102 Investment manager
Ninety One Uk Limited 2102 Investment manager
Baillie Gifford & Co 2102 Investment manager

Hangzhou Tigermed Consulting Co (HKSE:03347) Headlines

No Headlines